Marine heatwaves will become a regular occurrenc
Author: Michael
Phase II trial finds durvalumab plus ceralaserti
New findings show that coral bleaching prompts t
In the late 1980s, at a federal research facility
A busy week of science and prep for an upcoming
What’s more rewarding for an angel investor tha
Finom, a European challenger bank aimed at SMEs a
Shielded by the jungle for hundreds of years, the
A private Houston-based company is set this week t
New research highlights the role of microorganis